Condition: Acute Heart Failure (AHF) · Cardiogenic Shock · Heart Failure · Sponsor: Institute for Clinical and Experimental Medicine
This study will evaluate the feasibility and safety of achieving therapeutic concentrations of beta-hydroxybutyrate using continuous infusion of D-beta-hydroxybutyrate monoester administered via a nasogastric tube in patients with acutely decompensated heart failure with reduced left ventricular ejection fraction.
This description comes directly from the study's public registry record.
Marek Sramko, MD, PhD · +420776246127 · marek.sramko@ikem.cz
Always discuss trial participation with your own doctor first.
| Institute for Clinical and Experimental Medicine (IKEM) | Prague, Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07527156